222 related articles for article (PubMed ID: 20024841)
1. Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
Thorneloe KS
IDrugs; 2010 Jan; 13(1):16-9. PubMed ID: 20024841
[TBL] [Abstract][Full Text] [Related]
2. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
Plane G
IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic scope of modulation of non-voltage-gated cation channels.
Li S; Gosling M; Poll CT; Westwick J; Cox B
Drug Discov Today; 2005 Jan; 10(2):129-37. PubMed ID: 15718162
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic scope of modulation of non-voltage-gated cation channels.
Li S; Gosling M; Poll CT; Westwick J; Cox B
Drug Discov Today; 2004 Dec; 9(24):1045-54. PubMed ID: 15582793
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
Marblestone JG
IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
[TBL] [Abstract][Full Text] [Related]
6. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
Bodovitz S
IDrugs; 2010 Jan; 13(1):23-5. PubMed ID: 20024843
[TBL] [Abstract][Full Text] [Related]
7. HDAC Inhibitors--CHI's Third Annual Conference.
Rosato RR
IDrugs; 2010 Jan; 13(1):13-5. PubMed ID: 20024840
[TBL] [Abstract][Full Text] [Related]
8. Ion channel modulators: new targets and new indications for old targets.
Priest B; Kaczorowski GJ; Garcia ML
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):587-94. PubMed ID: 17002219
[TBL] [Abstract][Full Text] [Related]
9. Discovery on Target 2007--CHI's Fifth Annual Conference. Ion channels.
Beeton C
IDrugs; 2007 Dec; 10(12):851-4. PubMed ID: 18041678
[No Abstract] [Full Text] [Related]
10. [Mitochondrial ion channels].
Debska G; Kicińska A; Skalska J; Berest V; Szewczyk A
Postepy Hig Med Dosw; 2002; 56(3):315-21. PubMed ID: 12194244
[TBL] [Abstract][Full Text] [Related]
11. [Ion channels and epilepsy].
Armijo JA; de las Cuevas I; Adín J
Rev Neurol; 2000 Jun; 30 Suppl 1():S25-41. PubMed ID: 10904966
[TBL] [Abstract][Full Text] [Related]
12. Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases.
Varga Z; Hajdu P; Panyi G
Immunol Lett; 2010 May; 130(1-2):19-25. PubMed ID: 20026117
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches to ion channel diseases.
Camerino DC; Desaphy JF; Tricarico D; Pierno S; Liantonio A
Adv Genet; 2008; 64():81-145. PubMed ID: 19161833
[TBL] [Abstract][Full Text] [Related]
14. [Animal toxins and ion channels].
Darbon H
J Soc Biol; 1999; 193(6):445-50. PubMed ID: 10783702
[TBL] [Abstract][Full Text] [Related]
15. Ion channels as potential targets for the treatment of depression.
Lodge NJ; Li YW
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):633-41. PubMed ID: 18729015
[TBL] [Abstract][Full Text] [Related]
16. European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain.
Wong NC
IDrugs; 2009 Nov; 12(11):675-8. PubMed ID: 19844849
[TBL] [Abstract][Full Text] [Related]
17. Ion channels as novel therapeutic targets in the treatment of pain.
Mathie A
J Pharm Pharmacol; 2010 Sep; 62(9):1089-95. PubMed ID: 20796186
[TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine.
Nilius B; Szallasi A
Pharmacol Rev; 2014 Jul; 66(3):676-814. PubMed ID: 24951385
[TBL] [Abstract][Full Text] [Related]
19. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.
Dunlop J; Bowlby M; Peri R; Vasilyev D; Arias R
Nat Rev Drug Discov; 2008 Apr; 7(4):358-68. PubMed ID: 18356919
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials in CNS--SMi's eighth annual conference.
Kirk R
IDrugs; 2010 Feb; 13(2):66-9. PubMed ID: 20127552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
